Published by Josh White on 1st November 2022
(Sharecast News) - Biopharmaceutical company Arecor Therapeutics announced on Tuesday that its subsidiary Tetris Pharma has launched the 'Ogluo' glucagon-prefilled autoinjector pen as a treatment for severe hypoglycaemia in children and adults living with diabetes in Germany.
URL: http://www.digitallook.com/dl/news/story/33077204/...